Financials data is unavailable for this security.
View more
Year on year Animalcare Group plc had net income fall -38.98% from 1.97m to 1.20m despite a 3.82% increase in revenues from 71.62m to 74.35m. An increase in the selling, general and administrative costs as a percentage of sales from 38.43% to 41.81% was a component in the falling net income despite rising revenues.
| Gross margin | 58.30% |
|---|---|
| Net profit margin | 1.61% |
| Operating margin | 5.93% |
| Return on assets | 1.07% |
|---|---|
| Return on equity | 1.53% |
| Return on investment | 1.30% |
More ▼
Cash flow in GBPView more
In 2023, cash reserves at Animalcare Group plc fell by 1.39m. However, the company earned 10.93m from its operations for a Cash Flow Margin of 14.70%. In addition the company used 2.86m on investing activities and also paid 9.60m in financing cash flows.
| Cash flow per share | 0.1451 |
|---|---|
| Price/Cash flow per share | 16.10 |
| Book value per share | 1.30 |
|---|---|
| Tangible book value per share | 0.1107 |
More ▼
Balance sheet in GBPView more
| Current ratio | 1.60 |
|---|---|
| Quick ratio | 1.05 |
| Total debt/total equity | 0.0754 |
|---|---|
| Total debt/total capital | 0.0701 |
More ▼
Growth rates in GBP
Year on year, growth in dividends per share increased 13.64% while earnings per share excluding extraordinary items fell by -38.83%. The positive trend in dividend payments is noteworthy since very few companies in the Biotechnology & Drugs industry pay a dividend. Additionally, five year annualized dividend per share growth is in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 1.86% |
|---|---|
| Div growth rate (5 year) | 2.59% |
| Payout ratio (TTM) | 150.38% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -38.91 |
More ▼
